Cargando…
Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague
Inhalation of Yersinia pestis can lead to pneumonic plague, which without treatment is inevitably fatal. Two novel formulations of liposome-encapsulated ciprofloxacin, ‘ciprofloxacin for inhalation’ (CFI, Lipoquin(®)) and ‘dual release ciprofloxacin for inhalation’ (DRCFI, Pulmaquin(®)) containing C...
Autores principales: | Hamblin, Karleigh A., Armstrong, Stuart J., Barnes, Kay B., Davies, Carwyn, Laws, Thomas, Blanchard, James D., Harding, Sarah V., Atkins, Helen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292416/ https://www.ncbi.nlm.nih.gov/pubmed/28220110 http://dx.doi.org/10.3389/fmicb.2017.00091 |
Ejemplares similares
-
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
por: Hamblin, Karleigh A., et al.
Publicado: (2014) -
Efficacy of finafloxacin in a murine model of inhalational glanders
por: Barnes, Kay B., et al.
Publicado: (2022) -
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei
por: Barnes, Kay B., et al.
Publicado: (2017) -
Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection
por: Barnes, Kay B., et al.
Publicado: (2021) -
Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax
por: Stratilo, Chad W., et al.
Publicado: (2020)